Lung cancer mortality and municipal marginalization in Mexico, 1998-2016.

OBJECTIVE To analyze the mortality trend of lung cancer (LC) in Mexico, according to the municipality marginalization index (MMI) by age group and sex, during the period 1998-2016. MATERIALS AND METHODS The information on mortality, population and MMI was obtained from the National Institute of Statistics and Geography (INEGI) and the National Council of Population (Conapo). The adjusted LC mortality rate trends were analyzed using the joinpoint regression analysis. A total of 126 132 deaths were included. RESULTS The adjusted LC mortality rate decreased from 7.83 to 4.97 100 000 inhabitants during the period from 1998-2016, but the decrease was found to be less in women and in areas with very high marginalization. CONCLUSIONS Unequal reduction in LC mortality according to the degree of marginalization are related to early diagnosis, timely treatment and inequity in medical services. This inequity affects mainly the populations of women, highly marginalized groups and older populations.

[1]  Chin-Shang Li,et al.  Disparities in Systemic Treatment Use in Advanced-stage Non–Small Cell Lung Cancer by Source of Health Insurance , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[2]  E. Hernández-Garduño,et al.  Lung cancer mortality trends in Mexico, 1999-2014. , 2018, Salud publica de Mexico.

[3]  C. Vallejos,et al.  The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. , 2018, Lung cancer.

[4]  J. Benneyan,et al.  Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review. , 2017, Lung cancer.

[5]  E. Hernández-Garduño,et al.  Prevalence trends of wood use as the main cooking fuel in Mexico, 1990-2013. , 2017, Salud publica de Mexico.

[6]  Jean Adams,et al.  Socio-economic inequalities in stage at diagnosis, and in time intervals on the lung cancer pathway from first symptom to treatment: systematic review and meta-analysis , 2016, Thorax.

[7]  C. Tworek,et al.  Disparities in Lung Cancer Care and Outcomes among Elderly in a Medically Underserved State Population-A Cancer Registry-Linked Database Study. , 2016, Population health management.

[8]  O. Arrieta,et al.  Proposals for the prevention of lung cancer in the health system of Mexico. , 2016, Salud publica de Mexico.

[9]  Tianhong Li,et al.  Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Perez-Padilla,et al.  [National consensus of diagnosis and treatment of non-small cell lung cancer]. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[11]  Martin White,et al.  Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis , 2013, PLoS medicine.

[12]  A. Cardona,et al.  Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non–Small-Cell Lung Cancer Related to Wood-Smoke Exposure , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  L. Koniaris,et al.  Do racial or socioeconomic disparities exist in lung cancer treatment? , 2010, Cancer.

[14]  Gregory L. Alexander,et al.  Marginalization and health geomatics , 2003, J. Biomed. Informatics.

[15]  A. Satterfield,et al.  TREATMENT , 1924, California and western medicine.